A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
about
Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer.Thymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with rectal adenocarcinoma.Irinotecan+5-fluorouracil with concomitant pre-operative radiotherapy in locally advanced non-resectable rectal cancer: a phase I/II study.Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer.Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2).Adjuvant therapy for rectal cancerTopoisomerase I inhibition in colorectal cancer: biomarkers and therapeutic targets.Toward the non-surgical management of locally advanced rectal cancer.CRLX101, a Nanoparticle-Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1α.Clinical and cellular roles for TDP1 and TOP1 in modulating colorectal cancer response to irinotecanAddition of oxaliplatin to capecitabine-based preoperative chemoradiotherapy for locally advanced rectal cancer: Long-term outcome of a phase II study.Combination of irinotecan and 5-fluorouracil with radiation in locally advanced rectal adenocarcinoma.
P2860
Q34499632-054B5F6D-A45B-4B12-B103-F864803B2EAAQ34743494-356A5F36-4D19-4236-AB62-00DC3E2607CDQ36608578-09D89E13-2231-4E7C-A5F3-CFAA3923692CQ36610647-5B9FF6B3-1027-4079-BB71-422D83EBE050Q37345327-CB954BAD-227B-4EB2-86F2-CE4DD99AEC7BQ37462241-7FCBDA54-5C87-4CC8-8BB9-ED863673AD6DQ37959718-8997A598-8BF7-4580-88E1-0EEF0CD9CFCCQ37998384-9CF7DCF2-E153-4BC0-9DE1-D41BAD32AC95Q38736426-F926DFA3-0837-40DB-A17D-6A7542CA68E0Q38927275-A2C335AC-502D-417E-AE26-06FD45A64454Q43623679-E9D5DCFE-E344-440E-9618-457F29E34A51Q46539596-F3DDCDF1-5DAA-40DE-9E73-7A3967BDF5C8
P2860
A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
A phase I/II study of irinotec ...... Clinical Oncology Group Study.
@ast
A phase I/II study of irinotec ...... Clinical Oncology Group Study.
@en
A phase I/II study of irinotec ...... Clinical Oncology Group Study.
@en-gb
type
label
A phase I/II study of irinotec ...... Clinical Oncology Group Study.
@ast
A phase I/II study of irinotec ...... Clinical Oncology Group Study.
@en
A phase I/II study of irinotec ...... Clinical Oncology Group Study.
@en-gb
prefLabel
A phase I/II study of irinotec ...... Clinical Oncology Group Study.
@ast
A phase I/II study of irinotec ...... Clinical Oncology Group Study.
@en
A phase I/II study of irinotec ...... Clinical Oncology Group Study.
@en-gb
P2093
P2860
P356
P1476
A phase I/II study of irinotec ...... Clinical Oncology Group Study.
@en
P2093
H M Meadows
R Glynne-Jones
T S Maughan
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603570
P407
P577
2007-01-30T00:00:00Z